SCHEMBL30824929

SCHEMBL30824929

CC(C)(O)c1ccc(Oc2ccc(OCC3CCNCC3)cc2)c(Br)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.48
▸ SLC6A2 P23975 6/20 0.44
▸ SLC6A4 P31645 6/20 0.44
▸ SLC6A3 Q01959 3/20 0.44
▸ HTR3A P46098 2/20 0.43
▸ KCNH2 Q12809 2/20 0.43
▸ KDM1A O60341 3/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ PIM2 Q9P1W9 1/20 0.39
▸ RBP4 P02753 1/20 0.39
▸ EP300 Q09472 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ KHK P50053 1/20 0.37
▸ ITGB3 P05106 1/20 0.37
▸ ITGA2B P08514 1/20 0.37
▸ CYP2D6 P10635 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30824928 1.00 TDP1 (0.48) TDP1SLC6A2SLC6A4SLC6A3HTR3A
SCHEMBL27392263 1.00 TDP1 (0.48) TDP1SLC6A2SLC6A4SLC6A3HTR3A
SCHEMBL30812277 0.82 SLC6A4 (0.38) TDP1SLC6A4KDM1AEP300MAOB
SCHEMBL27391178 0.79 SLC6A4 (0.34) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL30824898 0.79 SLC6A4 (0.34) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL27392262 0.78 TDP1 (0.49) TDP1SLC6A2SLC6A4SLC6A3HTR3A
SCHEMBL30812128 0.78 TRPV1 (0.33) SLC6A4KDM1ARBP4EP300HRH3
SCHEMBL30824822 0.77 BRD4 (0.48) TDP1KDM1AMAOBITGB3ITGA2B
SCHEMBL27392241 0.77 BRD4 (0.48) TDP1KDM1AMAOBITGB3ITGA2B
SCHEMBL30824772 0.77 UTS2R (0.34) SLC6A4PIM1PIM2EP300CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054955-A1 HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2024-03-14 — — WO disclosed
Send feedback